Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway
Losing lean body mass can increase the risk of cardiovascular disease, all-cause mortality and diminished quality of life
Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks
van der Aart-van der Beek AB, Apperloo E, Jongs N, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 126.Karakasis P., Patoulias D., Pamporis K., Stachteas P., Bougioukas K.I., Klisic A., Fragakis N., Rizzo M
Combining tapering with sustained nutritional, physical activity, and behavioral strategies can help maintain weight loss